Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romina-Marina Sima has a total of 293 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Induced Abortion as a Family Planning Strategy in Romania: A Narrative Literature Review of Policy, Health Outcomes and Psychosocial Determinants

    by Fernanda-Ecaterina Augustin, Bashar Haj Hamoud, Liana Ples, Mircea-Octavian Poenaru, Gabriel-Petre Gorecki, Mihai-Daniel Dinu, Adrian Neacşu, Romina-Marina Sima

    Background: Induced abortion is a major component of reproductive health, with about one in four pregnancies worldwide ending in induced abortion and important implications for maternal morbidity and mortality. Romania’s history of restrictive pronatalist policies, very high post-1989 abortion rates, and subsequent family planning reforms provides an informative case for understanding abortion as a family planning strategy. Objectives: This narrative literature review synthesizes evidence on induced abortion with emphasis on Romania. It describes the evolution of abortion law and policy, summarizes epidemiological and maternal health outcomes, examines sociodemographic and psychosocial determinants of induced abortion, reviews psychological and psycho-sexual consequences, and discusses the role of non-stigmatizing terminology in clinical communication. Methods: This narrative literature review was informed by a structured literature search of PubMed, Scopus, and Web of Science Core Collection conducted on 20 May 2026. Publications from January 1990 to September 2024 were searched using terms related to induced abortion, family planning, Romania, maternal mortality and morbidity, abortion policy, psychosocial determinants, psychological outcomes, and stigma. Predefined eligibility criteria were used to identify relevant peer-reviewed studies and major institutional sources; additional historical and legal documents were considered for contextual framing. Additional recently published studies relevant to the review themes were identified through targeted update searches and reference-list screening up to 20 May 2026. Results: Restrictive policies and contraceptive bans in Romania were associated with extremely high abortion-related maternal mortality, whereas legal liberalization and integrated family planning programs led to marked declines in abortion rates and deaths. Abortion decisions reflect age, partnership, parity, education, employment and legal status. Psychological studies and major reviews report heterogeneous post-abortion experiences. These outcomes appear to be influenced primarily by pre-existing mental-health vulnerability, pregnancy intention and circumstances, social support, stigma, and decisional autonomy, rather than by the procedure alone. Also, terminology and conscientious objection practices can contribute to stigma and access barriers. Conclusions: Ensuring equitable access to contraception, safe abortion services, nonjudgmental counseling and neutral professional language appears essential for reducing preventable maternal morbidity and supporting reproductive autonomy.

  • Open Access

    Clinicopathological Characteristics and Treatment Patterns of Extremity, Trunk, and Axial Sarcomas: A Descriptive Real-World Cohort Study from a Romanian Tertiary Oncology Center

    by Mihai-Teodor Georgescu, Adelina Silvana Gheorghe, Romina-Marina Sima, Bashar Haj Hamoud, Georgia Luiza Serbanescu, Andreea Veronica Lazescu, Oana Gabriela Trifanescu, Radu Iulian Mitrica, Laurentia Nicoleta Gales, Roxana Rahnea-Nita, et al.

    Background and Objectives: Sarcomas are rare malignancies of mesenchymal origin comprising less than 1% of all adult solid tumors, exhibiting marked histological heterogeneity and variable clinical behavior. Data from Eastern European tertiary oncology centers remain scarce. This study characterized the clinicopathological features, treatment modalities, and survival outcomes of patients with sarcomas of the extremities and trunk treated at the “Prof. Dr. Alexandru Trestioreanu” Institute of Oncology from Bucharest over a ten-year period. Materials and Methods: We conducted a retrospective analysis of 164 patients diagnosed with sarcomas of the extremities and trunk between 2010 and 2020 at “Prof. Dr. Alexandru Trestioreanu” Institute of Oncology. Variables included age, sex, tumor localization, histological subtype, immunohistochemical profile, treatment modalities, recurrence, metastatic spread, and overall survival (OS). Kaplan–Meier curves estimated survival; log-rank tests were applied for subgroup comparisons. Results: The cohort comprised 82 males and 82 females (50.0% each), with a mean age of 48.8 ± 18.3 years. The lower limb was the most frequent site (n = 96, 58.5%), particularly the thigh/femur (34.1%). The most common subtypes were undifferentiated pleomorphic sarcoma (14.6%), osteosarcoma (12.2%), and fibrosarcoma (11.0%). Surgery was performed in 75.6%, chemotherapy in 80.5%, and radiotherapy in 59.8%. Local recurrence occurred in 35.4% and distant metastases in 41.5%. The median OS was 96.0 months (vital status known for 160/164 patients; 90 deceased, 70 alive; OS duration available in 126 patients). Metastatic disease was associated with shorter observed survival in descriptive Kaplan–Meier analysis (log-rank p < 0.001); this comparison is exploratory given the time-dependent nature of the variable. Survival ranged from 11.5 months (leiomyosarcoma) to 162.5 months (dermatofibrosarcoma protuberans) by histotype. Conclusions: This study provides clinically relevant epidemiological and survival data from Romania. The findings illustrate real-world heterogeneity of sarcoma presentations and outcomes at an Eastern European tertiary center and highlight the need for improved diagnostic standardization, prospective data collection, and integration within specialized sarcoma networks.

  • Open Access

    Urinary Catheterization Training for Nursing Students Using Traditional Instruction, Simulation, and Augmented Reality: A Randomized Controlled Trial

    by Daniela Dunca, Cristian Valentin Toma, Didina-Catalina Barbalata, Romina-Marina Sima, Nina Rosu, George Andrei Popescu, Ovidiu-Catalin Nechita, Daniel Liviu Badescu, Viorel Jinga

    (1) Background: Augmented reality (AR) simulation may accelerate psychomotor skill acquisition in clinical education, but comparative evidence is scarce. This three-arm randomized controlled trial compared AR simulation, basic task-trainer simulation, and lecture-based instruction for urinary catheterization training. We hypothesized that AR would be associated with higher performance compared to the other two methods. (2) Methods: Primary outcomes included male and female catheterization skills assessed with checklists. Secondary outcomes included knowledge and confidence. One-way ANOVA with Tukey’s HSD post hoc tests constituted the primary analysis; Kruskal–Wallis tests and Bayesian ANOVA provided convergent evidence. (3) Results: A total of 176 trainees were assigned to AR simulation, basic simulator, or lecture-only control groups (N = 60, 58, and 58, respectively). AR simulation was associated with higher skill scores than both basic simulation and the control for male catheterization (p < 0.001, η2 = 0.574) and female catheterization (p < 0.001, η2 = 0.535), with large effect sizes (Cohen’s d = 3.11, AR vs. control). Knowledge showed no group difference (p = 0.11). Confidence moderately favored AR (d = 0.69 vs. Control). Bayesian analysis supported a high probability of AR outperforming Control. (4) Conclusions: AR simulation training was associated with superior catheterization skills compared to both basic simulation and lecture-based instruction, with large effect sizes observed across both frequentist and Bayesian analyses. Knowledge was consistent across groups, suggesting a possible ceiling effect.

  • Open Access

    Approaches to Intraepithelial Cervical Neoplasia Management in Pregnancy: A Narrative Review

    by Delia-Maria Bogheanu, Awatif Jaafar Sadeq Al Bayati, Mircea-Octavian Poenaru, Octavian Gabriel Olaru, Gabriel-Petre Gorecki, Andreea Gratiana Boiangiu, Bashar Haj Hamoud, Romina-Marina Sima, Liana Ples

    This narrative review examines current evidence on the management of cervical intraepithelial neoplasia (CIN) during pregnancy, a clinical scenario requiring a balance between maternal oncologic safety and fetal well-being. A qualitative synthesis was conducted using major databases (PubMed, Google Scholar, Cochrane Library, and ScienceDirect), focusing on studies published between 2019 and 2025, supplemented by key earlier publications. A total of 37 studies and international guidelines were included. Available evidence suggests that pregnancy does not substantially alter the natural history of human papillomavirus infection. Although CIN is generally associated with low progression rates and notable postpartum regression, findings remain heterogeneous and largely based on retrospective data. Colposcopy is essential for excluding invasive disease, while invasive procedures are reserved for suspected malignancy. Most guidelines support conservative management with surveillance during pregnancy and postpartum reassessment. HPV testing offers higher sensitivity, whereas cytology remains widely used due to its specificity. The impact of delivery mode remains inconclusive. Overall, current recommendations rely on limited evidence and should be interpreted with caution. Further prospective studies are needed to refine pregnancy-specific management strategies.

  • Open Access

    Transdermal Hormonal Therapy in Menopause: Current Evidence and Personalized Approaches

    by Mara-Mădălina Mihai, Ana-Maria Toma, Cristian-Valentin Toma, Andra-Ioana Copilău, Cătălina-Ioana Naum, Maria-Alexandra Timofte, Ileana-Adela Văcăroiu, Andra-Elena Balcangiu Stroescu, Romina Marina Sima, Mircea-Octavian Poenaru

    Maintaining hormonal equilibrium is a key determinant of women’s health, particularly during the menopausal transition and postmenopause. The decline in ovarian estrogen and progesterone production influences multiple physiological systems, affecting many aspects like vasomotor stability, bone and cardiovascular health, cognitive function, mood, and metabolic regulation. As a result, many women may experience symptoms that impair daily functioning and increase long-term morbidity. Recent progress in menopausal care emphasizes individualized, evidence-guided treatment, supported by improved diagnostic tools that allow for a more precise assessment of endocrine changes during this life stage. Among the available therapeutic options, transdermal menopausal hormone therapy has gained growing recognition due to its ability to re-establish hormonal levels with fewer systemic effects. By bypassing first-pass hepatic metabolism, this route provides more consistent serum hormone concentrations and may be associated with a lower risk of metabolic and thromboembolic complications compared with oral formulations. This review brings together the physiological basis, clinical indications, and current scientific evidence related to transdermal hormonal therapy during menopause while also highlighting its expanding therapeutic role and integration into personalized treatment strategies. In addition, we discuss recent findings on its pharmacological profile, clinical effectiveness, and emerging perspectives that position this therapeutic option as an increasingly important component of modern menopausal care and women’s health management.

  • Open Access

    Therapeutic Termination of Pregnancy Under the Umbrella of Environmental, Socio-Economic Factors and High-Risk Pregnancy

    by Mihai-Daniel Dinu, Liana Ples, Fernanda-Ecaterina Augustin, Mara-Madalina Mihai, Ancuta-Alina Constantin, Gabriel-Petre Gorecki, Andrei-Sebastian Diaconescu, Mircea-Octavian Poenaru, Romina-Marina Sima

    Therapeutic termination of pregnancy (TToP) represents an intervention that is performed for medical reasons, such as risks to maternal health or severe fetal anomalies. Advances in prenatal screening and diagnostic tools—including serum markers, ultrasound, cell-free fetal DNA, chorionic villus sampling and amniocentesis—have significantly improved early detection and clinical decision-making. This narrative review synthesizes current knowledge on the genetic, environmental and psychosocial determinants that influence the decision of the patients to pursue TToP. The literature search was performed primarily using PubMed database, while Scopus and Google Scholar were used to identify additional relevant studies. Some of the selected studies, as well as certain sections of this review, address both therapeutic and voluntary termination of pregnancy, whereas others focus exclusively on TToP. Moreover, this review describes the types of abortion (medical or surgical/aspiration) along with their management strategies to prevent or address potential complications. It is well known that demographic, cultural and socio-economic factors continue to influence the access to TToP, as well as the perceptions of it. Psychiatric comorbidities (such as anxiety, affective and psychotic disorders) are observed with a higher prevalence among women undergoing TToP and may influence both the decision and psychological outcomes post-procedure. While most women report emotional relief after TToP, some of them experience depression, post-traumatic stress disorder or substance misuse. Legal and ethical considerations further complicate access to safe abortion, leading to situations where patients may resort to unsafe procedures, which result in higher rates of morbidity and mortality. Data from the EUROCAT network show rising trends in congenital anomalies like trisomy 13, trisomy 18 and caudal regression syndrome (conditions commonly associated with TToP). Therefore, it is mandatory to form a multidisciplinary team in these cases, integrating medical, psychological and ethical dimensions. Ensuring safe, evidence-based and compassionate access to TToP remains a critical component of reproductive healthcare.

  • Open Access

    Conservative Treatment in Stress Urinary Incontinence—Narrative Literature Review

    by Mircea-Octavian Poenaru, Liana Ples, Cristian-Valentin Toma, Fernanda-Ecaterina Augustin, Romina-Marina Sima, Mihaela Amza, Irina Pacu, Giorgia Zampieri, Andrei Sebastian Diaconescu, Daniela Poenaru

    Background: Stress urinary incontinence (SUI) is the most common subtype of urinary incontinence in women and significantly their affects quality of life. Aim: The aim of this study was to summarize the current evidence about conservative (non-surgical) treatments for female SUI and outline their clinical applicability. Material and methods: A narrative review was performed using structured research involving medical databases over the last 15 years, including systematic reviews, randomized controlled trials, observational studies and key guidelines regarding pelvic floor muscle training (PFMT), electrical and tibial nerve stimulation, acupuncture, pharmacological therapies, local estrogen, pessaries and bulking agents. Results: PFMT represents the primary first-line therapy, with strongest evidence for reducing leakage episodes and improving quality of life when performed correctly and consistently. Other conservative options (electrical and tibial nerve stimulation, acupuncture, duloxetine, local vaginal estrogen, pessaries and bulking agents) may be efficient for selected patients, but generally they have a weaker or more heterogeneous evidence base. They are considered adjuncts or tailored alternatives when PFMT alone is insufficient, not feasible or not accepted. Conclusions: Conservative management, centered on PFMT, should be offered as initial treatment to most women with mild to moderate SUI, with additional modalities being used selectively according to symptom profile, comorbidities and patient preference. A stepwise, individualized approach can control symptoms in many women and may delay or avoid surgical therapy.


  • Open Access

    Environmental Pollution, Endocrine Disruptors, and Metabolic Status: Impact on Female Fertility—A Narrative Review

    by Cristina-Diana Popescu, Romina Marina Sima, Mircea-Octavian Poenaru, Ancuta-Alina Constantin, Gabriel-Petre Gorecki, Andrei-Sebastian Diaconescu, Mara Mihai, Cristian-Valentin Toma, Liana Pleș

    Objectives: Female fertility is increasingly threatened by environmental pollutants such as fine particulate matter (PM2.5 and NO2), endocrine-disrupting chemicals (BPA, phthalates, PFAS, and PCBs), and microplastics. These exposures are associated with impaired ovarian reserve, reduced implantation rates, and lower assisted reproductive technology (ART) success. Given the rising prevalence of obesity and weight-loss interventions, particularly bariatric surgery, understanding the combined influence of metabolic and environmental factors on reproductive outcomes is of critical importance. This review aimed to synthesize recent evidence on how these exposures interact to affect female fertility. Methods: A narrative review was conducted of studies published between 2019 and 2025 using PubMed, Google Scholar, Web of Science, and Wiley Online Library. The PubMed Boolean search string was “female fertility”, “ovarian function”, “IVF” and “pollution”, “endocrine disruptors”, “air pollutants”, and “microplastics”. Searches were limited to English language publications, with the last search performed on 30 March 2025. Human, animal, and in vitro data were screened separately. Human evidence was prioritized, and confounding factors (age, BMI, and smoking) were considered during interpretation. Results: Environmental pollutants were consistently associated with diminished ovarian reserve, poor oocyte quality, and reduced live birth rates in ART. PFAS exposure correlated with lower fecundability, while PM2.5 and NO2 were linked to decreased AMH and AFC levels. Mechanistic animal and in vitro studies support these findings through pathways involving oxidative stress, endocrine disruption, and epigenetic alterations. Rapid metabolic changes, particularly post-bariatric surgery, may transiently increase circulating lipophilic toxicants and reduce antioxidant defenses, amplifying reproductive vulnerability. Conclusions: Environmental exposures, especially PM2.5, NO2, PFAS, and microplastics, adversely influence ovarian and embryonic competence. Rapid metabolic transitions may further modulate this susceptibility through pollutant mobilization and micronutrient imbalances. Future interdisciplinary prospective studies integrating exposure monitoring, metabolic profiling, and reproductive endpoints are essential to guide clinical recommendations and precision fertility counseling.


  • Open Access

    Multicentric and Multifocal Breast Tumors—Narrative Literature Review

    by Mircea-Octavian Poenaru, Mihaela Amza, Cristian-Valentin Toma, Fernanda-Ecaterina Augustin, Irina Pacu, Giorgia Zampieri, Liana Ples, Romina-Marina Sima, Andrei-Sebastian Diaconescu

    Background: Multifocal (MF) and multicentric (MC) breast cancers, defined by the presence of multiple synchronous tumor foci within the same breast, present important diagnostic, therapeutic, and prognostic challenges. Historically considered a contraindication for breast-conserving therapy (BCT), advances in imaging, surgical techniques, and adjuvant therapy have reshaped management strategies. Methods: A narrative literature review was conducted through PubMed, Web of Science, and Scopus, prioritizing ISI-indexed articles published within the last 10–15 years. More than 55 relevant studies, including systematic reviews, meta-analyses, and large cohorts, were analyzed to evaluate epidemiology, pathological features, imaging modalities, treatment outcomes, and prognosis of MF/MC breast cancers. Results: The reported incidence of MF/MC breast cancers ranges from 10% to 24%, increasing when MRI or whole-organ pathology is applied. MRI can detect otherwise occult additional foci in up to 30% of patients, improving staging accuracy but raising concerns of overdiagnosis. MF/MC presentation is strongly associated with lobular histology, younger age at diagnosis, and higher rates of axillary involvement—nodal positivity is observed in up to 45% of MF/MC cases versus 28% in unifocal tumors. Pathological analyses demonstrate frequent clonal origin of MF lesions, whereas MC lesions may represent independent primaries, occasionally with receptor heterogeneity that alters systemic therapy selection. From a prognostic perspective, older series suggested shorter breast cancer-specific survival (e.g., median 154 vs. 204 months for MF/MC vs. unifocal disease), and higher local recurrence with BCT. However, contemporary analyses, including a 2022 meta-analysis of 15,703 patients, demonstrated no significant difference in overall or disease-free survival once adjusted for tumor size and nodal status. Local recurrence remains slightly higher with BCT in MF/MC (5.6% vs. 4.2%), but outcomes are equivalent to mastectomy when radiotherapy is appropriately delivered. Five-year survival in early-stage MF/MC exceeds 90% with guideline-concordant multimodal therapy. Conclusions: MF/MC breast cancers represent a biologically heterogeneous entity. Optimal outcomes rely on precise imaging, complete excision, tailored systemic therapy, and multidisciplinary management, with increasing acceptance of breast conservation in selected patients.


  • Open Access

    Fertility Preservation Strategies in Female Cancer Patients: Current Approaches and Future Directions

    by Nicolae Gică, Ioana Vișoiu, Ioana-Catalina Mocanu, Ancuța Năstac, Romina Marina Sima, Anca Maria Panaitescu, Claudia Mehedințu

    Fertility-sparing treatments (FSTs) have gained importance for young female cancer patients, especially those with early-stage cervical, ovarian, and endometrial cancers. However, concerns about the long-term safety of these procedures, particularly in more advanced cancers, persist. A literature review was conducted using databases such as PubMed, Scopus, and Web of Science. The search terms included “fertility preservation” and “gynaecological cancer”. Articles published between 2014 and 2024 were considered, with 39 articles cited in the paper. The inclusion criteria were female patients undergoing FST. Studies were excluded if prior treatments impacted fertility or if oncological outcomes were inadequately reported. Radical trachelectomy, laparoscopic fertility-sparing surgeries, and cryopreservation techniques, such as ovarian tissue vitrification and oocyte cryopreservation, offer viable options for preserving fertility in early-stage gynecological cancer patients. Radical trachelectomy and cryopreservation showed positive reproductive outcomes, with pregnancy rates of 30–50% in early-stage cases. GnRH analogs during chemotherapy also demonstrated benefits in maintaining fertility. Despite these advances, recurrence in more advanced stages (FIGO IA2 and beyond) remains a concern. Minimally invasive surgeries like robotic-assisted procedures demonstrated comparable fertility outcomes to traditional methods but with fewer complications. FST is a promising option for women with early-stage cancer, offering favorable reproductive and survival outcomes. However, further research is needed to confirm long-term oncological safety in advanced stages. Multidisciplinary approaches and individualized treatment planning are essential for optimizing outcomes.